a strong trendp = 0.058
HL-1 CMs tolerated the shATG7 treatment, and analysis of ROS production after RNAi showed a strong trend toward ATG7 increasing ROS production (1.13 ± 0.05 vs. 1.26 ± 0.07 F ∗ s –1 , p = 0.058) ( Figure 2H ).
HL-1 CMs tolerated the shATG7 treatment, and analysis of ROS production after RNAi showed a strong trend toward ATG7 increasing ROS production (1.13 ± 0.05 vs. 1.26 ± 0.07 F ∗ s –1 , p = 0.058) ( Figure 2H ).